Elekta AB (publ)
OTC: EKTAF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Jakob Just-Bomholt
- Employees
- 4,541
- Headquarters
- Stockholm, Sweden
- IPO year
- 2010
- Market cap
- $1.9B
- Website
- https://www.elekta.com
Loading EKTAF…
Loading profile data…Frequently asked questions about EKTAF
What does Elekta AB (publ) (EKTAF) do?
Elekta AB (publ) is a global medical technology enterprise providing advanced clinical tools for the treatment of cancer and neurological conditions. Their extensive product portfolio includes leading solutions for radiotherapy, such as Versa HD for brain metastases, the innovative Elekta Unity MR-Linac, Elekta Harmony linear accelerator, and sy...
Where does EKTAF trade?
Elekta AB (publ) (EKTAF) trades on the Other OTC.
What sector is EKTAF in?
Elekta AB (publ) (EKTAF) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Elekta AB (publ)?
Jakob Just-Bomholt is the chief executive officer of Elekta AB (publ) (EKTAF).
Where is Elekta AB (publ) headquartered?
Elekta AB (publ) is headquartered in Sweden.
Does EKTAF pay a dividend?
Yes — Elekta AB (publ) (EKTAF) paid a trailing twelve-month dividend of USD 0.26 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did EKTAF go public?
Elekta AB (publ) (EKTAF) completed its initial public offering in 2010.